The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Cytochrome P450 and Vascular Homeostasis
Abstract
Since the initial reports that renal cytochrome P450 (CYP) enzymes can metabolize arachidonic acid to substances which affect arterial tone, it has become increasingly clear that CYP enzymes expressed within the cardiovascular system play a crucial role in the modulation of vascular homeostasis. There is strong evidence suggesting that the activation of a CYP epoxygenase in endothelial cells is an essential step in nitric oxide and prostacyclin-independent vasodilatation of several vascular beds, particularly in the heart and kidney. A smooth muscle CYP ω-hydroxylase, on the other hand, generates a vasoconstrictor eicosanoid that is central to the myogenic response. Moreover, CYP epoxygenase and ω-hydroxylase products, as well as CYP-derived reactive oxygen species, are intracellular signal transduction molecules involved in several signaling cascades affecting numerous cellular processes, including vascular cell proliferation and angiogenesis. This review summarizes the vascular effects of epoxyeicosatrienoic acids and 20-hydroxyeicosatetraenoic acid, both of which are CYP-derived metabolites of arachidonic acid, endogenously generated within endothelial and vascular smooth muscle cells. Although the link between CYP expression/activity and cardiovascular disease is currently tentative, the evidence being accumulated to suggest that CYP pathways are altered in animal models of hypertension and atherosclerosis can no longer be ignored. The development of selective pharmacological tools is, however, a prerequisite for the analysis of the involvement of specific CYP isoforms in the regulation of vascular homeostasis in human subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The presence of these proteins in endothelial cells makes them a significant source of superoxide in the vasculature (295, 298).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [295]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytochrome P-450: Structure, Mechanism, and Biochemistry
de Montellano, O., & Paul, R. (1986) · Medical Entomology and Zoology · Cited by 2,663
Signal Transduction through MAP Kinase Cascades
Lewis, T. S., Shapiro, P. S., & Ahn, N. G. (1998) · Advances in cancer research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,759
On the local reactions of the arterial wall to changes of internal pressure
Bayliss, W. M. (1902) · The Journal of Physiology · doi:10.1113/jphysiol.1902.sp000911 · Cited by 1,526
Identification of Epoxyeicosatrienoic Acids as Endothelium-Derived Hyperpolarizing Factors
Campbell, W. B., Gebremedhin, D., Pratt, P. F., & Harder, D. R. (1996) · Circulation Research · doi:10.1161/01.res.78.3.415 · Cited by 1,221
Anti-inflammatory Properties of Cytochrome P450 Epoxygenase-Derived Eicosanoids
Node, K., Huo, Y., Ruan, X.-L., Yang, B., Spiecker, M., Ley, K. F., Zeldin, D. C., & Liao, J. K. (1999) · Science · doi:10.1126/science.285.5431.1276 · Cited by 1,218
Cytochrome P450 2C is an EDHF synthase in coronary arteries
Fißlthaler, B., Popp, R., Kiss, L., Potente, M., Harder, D. R., Fleming, I., & Busse, R. (1999) · Nature · doi:10.1038/46816 · Cited by 911
Self-citationGuengerich, F. P. (1995) · Springer eBooks · doi:10.1007/978-1-4757-2391-5_14 · Cited by 732
Cytochrome P450 and the Individuality of Species
Nelson, D. R. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1352 · Cited by 598
Capdevila, J. H., Falck, J. R., & Harris, R. C. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32049-6 · Cited by 559
Wolfrum, C., Borrmann, C. M., Börchers, T., & Spener, F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051619898 · Cited by 506
Flagged first, then by citations
Research works printed but not linked: 24
- 10.1161/hyp.25.4.854 · DOI
- 10.1161/res.81.2.258 · DOI
- 10.1161/res.83.5.501 · DOI
- 10.1161/circ.103.15.1992 · DOI
- 10.1161/res.78.3.415 · DOI
- 10.1161/circ.99.24.3132 · DOI
- 10.1161/res.88.1.44 · DOI
- 10.1161/circ.94.12.3341 · DOI
- 10.1161/str.28.5.1066 · DOI
- 10.1161/res.66.3.2306810 · DOI
- 10.1161/hyp.37.3.887 · DOI
- 10.1161/hyp.29.1.320 · DOI
- 10.1161/res.83.11.1069 · DOI
- 10.1161/str.27.5.971 · DOI
- 10.1161/res.82.6.696 · DOI
- 10.1161/res.81.5.797 · DOI
- 10.1161/circ.96.10.3610 · DOI
- 10.1161/res.85.4.349 · DOI
- 10.1161/res.80.6.877 · DOI
- 10.1161/hyp.31.1.242 · DOI
- 10.1161/hyp.33.1.408 · DOI
- 10.1161/circ.100.13.1400 · DOI
- 10.1161/res.79.4.784 · DOI
- 10.1161/res.87.11.992 · DOI
Cited by
Sorted by citations
Items 101–200 of 384
Fleming, I. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.08.002 · Cited by 69
Self-citationPallone, T. L., Edwards, A., & Mattson, D. L. (2012) · Comprehensive physiology · doi:10.1002/cphy.c100036 · Cited by 72
Gene–Smoking Interactions Identify Several Novel Blood Pressure Loci in the Framingham Heart Study
Sung, Y. J., Fuentes, L. D. L., Schwander, K., Simino, J. M., & Rao, D. C. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu149 · Cited by 65
Cytochrome P450 2J2: Potential Role in Drug Metabolism and Cardiotoxicity
Solanki, M. S., Pointon, A., Jones, B., & Herbert, K. E. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.078964 · Cited by 64
Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells
Niederberger, E., Manderscheid, C., Grösch, S., Schmidt, H., Ehnert, C., & Geißlinger, G. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.03.029 · Cited by 64
Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy‐induced bone loss
Guan, H., Zhao, L., Cao, H., Chen, A., & Xiao, J. (2014) · The FASEB Journal · doi:10.1096/fj.14-262055 · Cited by 64
Cui, W., Wu, X., Shi, Y., Guo, W., Luo, J., Liu, H., Zheng, L., Du, Y., WANG, P. H., Wang, Q., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12964 · Cited by 63
Swales, K. E., Moore, R., Truss, N. J., Tucker, A. T., Warner, T. D., Negishi, M., & Bishop‐Bailey, D. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr330 · Cited by 62
A Role for Heterocellular Coupling and EETs in Dilation of Rat Cremaster Arteries
McSherry, I. N., Sandow, S. L., Campbell, W. B., Falck, J. R., Hill, M. A., & Dora, K. A. (2006) · Microcirculation · doi:10.1080/10739680500466400 · Cited by 62
Schmidt, K., Hughes, C., Chudek, J. A., Goodyear, S. R., Aspden, R. M., Talbot, R., Gundersen, T. E., Blomhoff, R., Henderson, C., Wolf, C. R., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01638-08 · Cited by 61
Renal vascular cytochrome P450-derived eicosanoids in androgen-induced hypertension.
Singh, H., & Schwartzman, M. L. (2008) · PubMed · Cited by 61
Gross, E. R. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.10.008 · Cited by 58
Revermann, M., Barbosa‐Sicard, E., Dony, E., SCHERMULY, R. T., Morisseau, C. H. P., Geißlinger, G., Fleming, I., Hammock, B. D., & Brandes, R. P. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32831aedfa · Cited by 58
Self-citationPolonikov, A., Ivanov, V. P., Solodilova, M. A., Khoroshaya, I. V., Кожухов, М. А., Ivakin, V. E., Katargina, L. N., & Kolesnikova, O. V. (2008) · Disease Markers · doi:10.1155/2008/626430 · Cited by 57
CYP2C9 allele variants in Chinese hypertension patients and healthy controls
Yu, B., Luo, C., Wang, D., Wang, A., Li, Z., Zhang, W., Mo, W., & Zhou, H. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.04.028 · Cited by 57
Prenatal Hypoxia and Placental Oxidative Stress: Insights from Animal Models to Clinical Evidences
Silvestro, S., Calcaterra, V., Pelizzo, G., Bramanti, P., & Mazzon, E. (2020) · Antioxidants · doi:10.3390/antiox9050414 · Cited by 58
Guo, M., Roman, R. J., Falck, J. R., Edwards, P. A., & Scicli, A. G. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088567 · Cited by 56
Pannirselvam, M., Ding, H., Anderson, T. J., & Triggle, C. R. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.086 · Cited by 55
Endocannabinoid metabolism by cytochrome P450 monooxygenases
Zelasko, S. E., Arnold, W. R., & Das, A. (2014) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2014.11.002 · Cited by 61
Bioactive lipid mediators in polycystic kidney disease
Klawitter, J., Jj, K., McFann, K., Pennington, A. T., Abebe, K. Z., Brosnahan, G., Cadnapaphornchai, M. A., Chonchol, M., Gitomer, B., Christians, U., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.p042176 · Cited by 53
Cyp1B1 expression promotes angiogenesis by suppressing NF-κB activity
Palenski, T. L., Gürel, Z., Sorenson, C. M., Hankenson, K. D., & Sheibani, N. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00139.2013 · Cited by 53
Analysis of CYP2C9*5 in Caucasian, Oriental and Black-African populations
Yaşar, Ü., Aklillu, E., Canaparo, R., Sandberg, M., Sayi, J., Roh, H., & Wennerholm, A. (2002) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0518-6 · Cited by 53
Teraoka, H., Kubota, A., Dong, W., Kawai, Y. K., Yamazaki, K., Mori, C., Harada, Y., Peterson, R. E., & Hiraga, T. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.09.021 · Cited by 51
Deng, S., Zhu, G., Liu, F., Zhang, H., Qin, X. Y., Li, L., & He, Z. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.03.009 · Cited by 51
Regulation of renal CYP4A expression and 20-HETE synthesis by nitric oxide in pregnant rats
Wang, M.-H., Wang, J., Chang, H.-H., Zand, B. A., Jiang, M., Nasjletti, A., & Schwartzman, M. L. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00065.2003 · Cited by 51
Lifelong inorganic arsenic compounds consumption affected blood pressure in rats
Yang, H.-T., Chou, H.-J., Han, B., & Huang, S. (2007) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.05.024 · Cited by 49
Polonikov, A., Харченко, А. В., Быканова, М. А., Sirotina, S., Ponomarenko, I., Бочарова, А. В., Vagaytseva, K., Степанов, В. А., Bushueva, O. Y., Churnosov, M. I., et al. (2017) · Gene · doi:10.1016/j.gene.2017.07.004 · Cited by 50
Fißlthaler, B., Michaelis, U. R., Randriamboavonjy, V., Busse, R., & Fleming, I. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00492-0 · Cited by 49
Self-citationNavar, L. G., Arendshorst, W. J., Pallone, T. L., Inscho, E. W., Imig, J. D., & Bell, P. D. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374530-9.00015-2 · Cited by 45
Role of CYP epoxygenases in A2AAR-mediated relaxation using A2AAR-null and wild-type mice
Nayeem, M. A., Poloyac, S. M., Falck, J. R., Zeldin, D. C., Ledent, C. A., Ponnoth, D. S., Ansari, H. R., & Mustafa, S. J. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01333.2007 · Cited by 48
Makino, A., Firth, A. L., & Yuan, J. X. ‐. (2011) · Comprehensive physiology · doi:10.1002/cphy.c100023 · Cited by 52
Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide
Fang, X., Weintraub, N. L., Oltman, C. L., Stoll, L. L., Kaduce, T. L., Harmon, S. D., Dellsperger, K. C., Morisseau, C. H. P., Hammock, B. D., & Spector, A. A. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00448.2002 · Cited by 45
[Cytochromes P450: xenobiotic metabolism, regulation and clinical importance].
Guéguen, Y., Mouzat, K., Ferrari, L., Tissandié, E., Lobaccaro, J. M., Batt, A.-M., Paquet, F., Voisin, P., Aigueperse, J., Gourmelon, P., et al. (2006) · PubMed · doi:10.1684/abc.2006.0015 · Cited by 45
Yamaura, K., Gebremedhin, D., Zhang, C., Narayanan, J., Hoefert, K., Jacobs, E. R., Koehler, R. C., & Harder, D. R. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.021 · Cited by 45
Gueler, F., Rong, S., Mengel, M., Park, J.-K., Kiyan, Y., Kirsch, T., Dumler, I., Haller, H. G., & Shushakova, N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1179 · Cited by 44
Barden, A. E., Zilkens, R., Croft, K. D., Mori, T. A., Burke, V., Beilin, L. J., & Puddey, I. B. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.004 · Cited by 44
Jiang, J. G., Chen, R. J., Xiao, B., Yang, S., Wang, J. N., Wang, Y., Cowart, L. A., Xiao, X., Wang, D. W., & Xia, Y. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.08.005 · Cited by 44
Characterization of Four New Mouse Cytochrome P450 Enzymes of the CYP2J Subfamily
Graves, J. P., Edin, M. L., Bradbury, J. A., Gruzdev, A., Cheng, J., Lih, F. B., Masinde, T., Qu, W., Clayton, N. P., Morrison, J. P., et al. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.049429 · Cited by 43
Liu, X., Huang, T., Li, L., Tang, Y., Tian, Y., Wang, S., & Fan, C. (2015) · PubMed Central · Cited by 42
Sirotina, S., Ponomarenko, I., Харченко, А. В., Быканова, М. А., Бочарова, А. В., Вагайцева, К. В., Степанов, В. А., Churnosov, M. I., Solodilova, M. A., & Polonikov, A. (2018) · Disease Markers · doi:10.1155/2018/5812802 · Cited by 42
Awumey, E. M., Hill, S. K., Diz, D. I., & Bukoski, R. D. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01042.2007 · Cited by 42
Posadino, A. M., Cossu, A., Giordo, R., Zinellu, A., Sotgia, S., Vardeu, A., Hoa, P. T., Deiana, L., Carru, C., & Pintus, G. (2013) · Cardiovascular Toxicology · doi:10.1007/s12012-013-9205-3 · Cited by 42
Intracellular Redox State as Target for Anti-Influenza Therapy: Are Antioxidants Always Effective?
Sgarbanti, R., Amatore, D., Celestino, I., Marcocci, M. E., Fraternale, A., Ciriolo, M. R., Magnani, M., Saladino, R., Garaci, E., Palamara, A. T., et al. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666141203125211 · Cited by 40
Li, N., Zhang, G., Yi, F.-X., Zou, A.-P., & Li, P. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00416.2004 · Cited by 41
Goniodysgenesis variability and activity of CYP1B1 genotypes in primary congenital glaucoma
García-Antón, M. T., Salazar, J. J., de Hoz, R., Rojas, B., Ramirez, A. I., Triviño, A., Aroca‐Aguilar, J., Garcia-Sanchez, J., Escribano, J., & Ramirez, J. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176386 · Cited by 40
Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis
Ercan, B., Ayaz, L., Çiçek, D., & Tamer, L. (2007) · Cell Biochemistry and Function · doi:10.1002/cbf.1437 · Cited by 40
Endothelial Cell Cytochrome P450 1A1 and 1B1: Up-Regulation by Shear Stress
Eskin, S. G., Turner, N. A., & McIntire, L. V. (2004) · Endothelium · doi:10.1080/10623320490432434 · Cited by 40
Local Regulation of Microvascular Perfusion
Davis, M. J., Hill, M. A., & Kuo, L. (2008) · Comprehensive physiology · doi:10.1002/cphy.cp020406 · Cited by 39
CYP1B1: A key regulator of redox homeostasis.
Falero-Perez, J., Song, Y., Sorenson, C. M., & Sheibani, N. (2018) · PubMed · Cited by 39
The Role of Cytochrome P450 Epoxygenases in Retinal Angiogenesis
Capozzi, M. E., McCollum, G. W., & Penn, J. S. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14216 · Cited by 40
King, L. B., & Freedman, B. D. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00822.x · Cited by 43
Characterization of androgen-regulated expression of CYP3A5 in human prostate
Moilanen, A., Hakkola, J., Vaarala, M. H., Kauppila, S., Hirvikoski, P. P., Vuoristo, J. T., Edwards, R. J., & Paavonen, T. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl222 · Cited by 39
Gielis, J. F., Beckers, P. A. J., Briedé, J. J., Cos, P., & Schil, P. E. V. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.03.32 · Cited by 38
Perrelli, A., & Retta, S. F. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.06.021 · Cited by 36
Honetschlägerová, Z., Husková, Z., Vaňourková, Z., Sporková, A., Kramer, H. J., Hwang, S. H., Tsai, H.-J., Hammock, B. D., Imig, J. D., Červenka, L., et al. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.199505 · Cited by 38
Walkowska, A., Kuczeriszka, M., Sadowski, J., Olszynski, K. H., Dobrowolski, L., Červenka, L., Hammock, B. D., & Kompanowska‐Jezierska, E. (2015) · Kidney & Blood Pressure Research · doi:10.1159/000368508 · Cited by 38
van der Horst, J., Manville, R. W., Hayes, K., Thomsen, M. B., Abbott, G. W., & Jepps, T. A. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.313997 · Cited by 39
Kubota, A., Stegeman, J. J., Woodin, B. R., Iwanaga, T., Harano, R., Peterson, R. E., Hiraga, T., & Teraoka, H. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.03.025 · Cited by 37
He, L., Lin, Y., Day, D. B., Teng, Y., Wang, X., Liu, X. L., Yan, E., Gong, J., Qin, J., Wang, X., et al. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.0c08150 · Cited by 36
Comparison of P 2 Receptor Subtypes Producing Dilation in Rat Intracerebral Arterioles
Horiuchi, T., Dietrich, H. H., Hongo, K., & Dacey, R. G. (2003) · Stroke · doi:10.1161/01.str.0000071527.10129.65 · Cited by 36
Human CYP1A1 variants lead to differential eicosapentaenoic acid metabolite patterns
Schwarz, D., Kisselev, P., Chernogolov, A. A., Schunck, W., & Roots, I. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.172 · Cited by 35
Allen, T., Iftinca, M., Cole, W. C., & Plane, F. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.031823 · Cited by 34
Kim, H. J., Ham, S. A., Paek, K. S., Hwang, J. S., Jung, S. Y., Kim, M. Y., Jin, H., Kang, E. S., Woo, I. S., Kim, H. J., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.091 · Cited by 33
ADP-induced pial arteriolar dilation in ovariectomized rats involves gap junctional communication
Xu, H., Santizo, R. A., Baughman, V. L., & Pelligrino, D. A. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00031.2002 · Cited by 33
Dalmasso, C., Maranon, R. O., Patil, C. N., Moulana, M., Romero, D. G., & Reckelhoff, J. F. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00458.2015 · Cited by 33
Transcriptional profiling of cytochrome P450 genes in the liver of adult zebrafish, Danio rerio
Kubota, A., Kawai, Y. K., Yamashita, N., Lee, J., Kondoh, D., Zhang, S., Nishi, Y., Suzuki, K., Kitazawa, T., & Teraoka, H. (2019) · The Journal of Toxicological Sciences · doi:10.2131/jts.44.347 · Cited by 32
Triggle, C. R., Ding, H., Anderson, T. J., & Pannirselvam, M. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000041845.62061.c9 · Cited by 32
Acrolein induces vasodilatation of rodent mesenteric bed via an EDHF-dependent mechanism
Awe, S. O., Adeagbo, A. S. O., D’Souza, S. E., Bhatnagar, A., & Conklin, D. J. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.08.008 · Cited by 32
HETEs/EETs in renal glomerular and epithelial cell functions
Natarajan, R. D. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00015-8 · Cited by 32
Khan, M., Mohan, I. K., Kutala, V. K., Kumbala, D. R., & Kuppusamy, P. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.129486 · Cited by 32
Bełtowski, J., Wójcicka, G., & Jamróz-Wiśniewska, A. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.041 · Cited by 31
Chehal, M. K., & Granville, D. J. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y05-139 · Cited by 31
Sulfaphenazole treatment restores endothelium-dependent vasodilation in diabetic mice
Elmi, S., Sallam, N. A., Rahman, M. M., Teng, X., Hunter, A. L., Moien‐Afshari, F., Khazaei, M., Granville, D. J., & Laher, I. (2007) · Vascular Pharmacology · doi:10.1016/j.vph.2007.09.001 · Cited by 31
Ho, Y., Lai, M.-Y., Yu, H., Huang, D.-K., Hsueh, W.-C., Tsai, T., & Lin, C.-C. (2008) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(08)60006-6 · Cited by 30
High-salt diet enhances mouse aortic relaxation through adenosine A2Areceptor via CYP epoxygenases
Nayeem, M. A., Ponnoth, D. S., Boegehold, M. A., Zeldin, D. C., Falck, J. R., & Mustafa, S. J. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90798.2008 · Cited by 30
20-HETE contributes to ischemia-induced angiogenesis
Chen, L., Joseph, G. U., Zhang, F. F., Nguyen, H., Jiang, H., Gotlinger, K. H., Falck, J. R., Yang, J., Schwartzman, M. L., & Guo, A. M. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.04.002 · Cited by 30
Fang, C., Gu, J., Xie, F., Behr, M. J., Yang, W., Abel, E. D., & Ding, X. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021881 · Cited by 29
Tunaru, S., Chennupati, R., Nüsing, R. M., & Offermanns, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163633 · Cited by 29
Impaired Neurovascular Coupling in the APPxPS1 Mouse Model of Alzheimer’s Disease
Rancillac, A., Geoffroy, H., & Rossier, J. (2012) · Current Alzheimer Research · doi:10.2174/156720512804142859 · Cited by 29
Fatty Acid Transduction of Nitric Oxide Signaling
Cole, M. P., & Freeman, B. Α. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-373866-0.00011-3 · Cited by 29
Ito, I., Jarajapu, Y. P. R., Guberski, D. L., Grant, M. B., & Knot, H. J. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1012 · Cited by 29
Physiological Significance and Expression of P450s in the Developing Eye
Choudhary, D., Jansson, I., Sarfarazi, M., & Schenkman, J. B. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600570149 · Cited by 29
Indapamide Lowers Blood Pressure by Increasing Production of Epoxyeicosatrienoic Acids in the Kidney
Ma, F., Lin, F., Chen, C., Cheng, J., Zeldin, D. C., Wang, Y., & Wang, D. W. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.085878 · Cited by 28
Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner
Lee, E., Wu, Z., Shon, J. C., & Liu, K. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.064345 · Cited by 28
Sacerdoti, D., Pesce, P., Pascoli, M. D., & Bolognesi, M. (2016) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2016.06.002 · Cited by 28
Edwards, J. M., McCarthy, C. G., & Wenceslau, C. F. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200417150121 · Cited by 32
Xenobiotic‐metabolizing Cytochromes P450 in Ontogeny: Evolving Perspective
Choudhary, D., Jansson, I., Sarfarazi, M., & Schenkman, J. B. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-200033447 · Cited by 28
Yi, X., Liao, D., Fu, X.-Q., Zhang, B., & Wang, C. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.29025 · Cited by 27
Donato, A. J., Eskurza, I., Jablonski, K., Gano, L. B., Pierce, G. L., & Seals, D. R. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90629.2008 · Cited by 27
EDHF-mediated vasodilation involves different mechanisms in normotensive and hypertensive rat lungs
Morio, Y., Carter, E. P., Oka, M., & McMurtry, I. F. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00831.2002 · Cited by 27
Nayeem, M. A., Zeldin, D. C., Boegehold, M. A., Morisseau, C. H. P., Marowsky, A., Ponnoth, D. S., Roush, K. P., & Falck, J. R. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00823.2009 · Cited by 27
Theuer, J., Shagdarsuren, E., Müller, D. N., Kaergel, E., Honeck, H., Park, J.-K., Fiebeler, A., Dechend, R., Haller, H. G., Luft, F. C., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2005.00075.x · Cited by 27
Cytochrome p450 enzymes and cardiovascular disease
Hunter, A. L., Cruz, R. P., Cheyne, B. M., McManus, B. M., & Granville, D. J. (2004) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y04-118 · Cited by 26
CYP2C8 polymorphism among the Portuguese
Cavaco, I., Piedade, R., Gil, J. P., & Ribeiro, V. (2006) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2006.030 · Cited by 26
Endothelium-derived hyperpolarizing factor and diabetes
Gao, X. J. (2011) · World Journal of Cardiology · doi:10.4330/wjc.v3.i1.25 · Cited by 25
Chadderdon, S. M., Belcik, J. T., Bader, L., Peters, D., Kievit, P., Alkayed, N. J., Kaul, S., Grove, K. L., & Lindner, J. R. (2016) · Diabetes · doi:10.2337/db15-1574 · Cited by 25
You, J., Marrelli, S. P., & Bryan, R. M. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200210000-00012 · Cited by 25
The Role of Adenosine A2AReceptor, CYP450s, and PPARs in the Regulation of Vascular Tone
Khayat, M. T. A., & Nayeem, M. A. (2017) · BioMed Research International · doi:10.1155/2017/1720920 · Cited by 24
Frömel, T., & Fleming, I. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6150 · Cited by 24
Self-citationEffect of cytochrome P450-dependent epoxyeicosanoids on Ristocetin-induced thrombocyte aggregation
Jung, F., Schulz, C., Blaschke, F., Müller, D. N., Mrowietz, C., Franke, R. P., Lendlein, A., & Schunck, W. (2012) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-2012-1614 · Cited by 24
Metadata
- Authors
- Fleming, I.
- Affiliations
- Goethe University Frankfurt (DE)
- Corresponding author
- Fleming, Ingrid
- ORCID
- Fleming, Ingrid
- Venue
- Circulation Research
- Published
- 2001-10-26
- Volume
- 89
- Issue
- 9
- Pages
- 753-762
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2168349092
- Cited by
- 383
- References
- 142
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 3 · 2023: 5 · 2022: 5 · 2021: 5 · 2020: 8 · 2019: 13 · 2018: 11 · 2017: 15 · 2016: 11 · 2015: 11 · 2014: 21 · 2013: 8 · 2012: 13
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (SFB 553)
- Servier
- Institut de Recherches Servier
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- cytochrome P450, vascular homeostasis, arachidonic acid metabolism, epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, endothelial cells, vascular smooth muscle cells, vasodilation, vasoconstriction, myogenic response, reactive oxygen species, signal transduction, angiogenesis, hypertension, atherosclerosis, cardiovascular disease
- MeSH terms
- Animals, Biological Factors, Cardiovascular System, Cytochrome P-450 Enzyme System, Endothelium, Vascular, Epoxy Compounds, Free Radicals, Homeostasis, Humans, Hydroxyeicosatetraenoic Acids, Mixed Function Oxygenases, Isoenzymes, Muscle, Smooth, Vascular, Vasomotor System, 8,11,14-Eicosatrienoic Acid, Arachidonic Acid, Cytochrome P-450 CYP4A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review